HATCHER GROUP (08365.HK): to Buy 51% Stake in Advanced Meditech Force

NewTimeSpace News: On 28 September 2026, Hatcher Group Limited (stock code: 08365.HK) announced that the Company (the Purchaser) and Vast Gain Ltd. (the Vendor) entered into a sale and purchase agreement, pursuant to which the Company agreed to acquire 51% of the issued share capital of Advanced Meditech Force (HK) Limited (the Target Company). The Target Company is a company incorporated in Hong Kong with limited liability and is principally engaged in the operation of cancer screening and early detection centre, AI-driven digital pathology, and the provision of turnkey solutions for cancer diagnosis and treatment. As at the date of the announcement, the Target Company is wholly and beneficially owned by the Vendor.

The announcement stated that, as the majority shareholder of the Target Company following completion of the Acquisition, the Purchaser shall assist the Target Company in fund-raising activities and provide or arrange the provision of related services like accounting, corporate secretarial and corporate finance services to the Target Company, while the Vendor shall use its best endeavor to assist the Target Company in establishing a cancer screening and early detection centre, along with the promotion and operational site deployment of AI-driven digital pathology, and the provision of turnkey solutions for cancer diagnosis and treatment.

The Company noted that precision oncology and digital pathology are vital growth areas in contemporary medical technology, driven by a dual-engine diagnostic platform that integrates liquid biopsy with AI-driven digital pathology. According to market analysis, the global cancer diagnostics market is projected to reach US$6 billion by 2030, a CAGR of approximately 6.7%, while the digital pathology market is expected to reach US$1.5 billion, a CAGR of approximately 8.6%. As all of the applicable percentage ratios in respect of the Acquisition are less than 5%, the Acquisition does not constitute a notifiable transaction under Chapter 19 of the GEM Listing Rules, and the announcement is made on a voluntary basis.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.